PRECIRIX
Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients.
PRECIRIX
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
Brussels, Brussels Hoofdstedelijk Gewest, Belgium
Country:
Belgium
Website Url:
http://www.precirix.com
Total Employee:
11+
Status:
Active
Total Funding:
117 M EUR
Technology used in webpage:
CrUX Dataset ReCAPTCHA V2 CrUX Top 10m
Similar Organizations
4D Pharma
4D Pharma PLC is a world leader in the development of live biotherapeutics.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
Pontifax
Pontifax investment in Series B - Precirix
Inkef
Inkef investment in Series B - Precirix
V-Bio Ventures
V-Bio Ventures investment in Series B - Precirix
BioMedPartners
BioMedPartners investment in Series B - Precirix
HealthCap
HealthCap investment in Series B - Precirix
Novo Holdings
Novo Holdings investment in Series B - Precirix
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Precirix
Gimv
Gimv investment in Series B - Precirix
Jeito Capital
Jeito Capital investment in Series B - Precirix
Gimv
Gimv investment in Series A - Precirix
Official Site Inspections
http://www.precirix.com Semrush global rank: 8.77 M Semrush visits lastest month: 528
- Host name: bitsoflove-web2.level27.eu
- IP address: 185.3.217.15
- Location: Belgium
- Latitude: 50.8509
- Longitude: 4.3447
- Timezone: Europe/Brussels
More informations about "Precirix"
About | Precirix
PRECIRIX is a private biotechnology company dedicated to extending and improving the lives of cancer patients by designing and developing precision radiopharmaceuticals, using camelid …See details»
Precirix - Crunchbase Company Profile & Funding
Organization. Precirix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Precirix is a …See details»
Careers - Precirix
At Precirix we care about people. We strive to improve the lives of cancer patients by developing novel radiopharmaceuticals that address unmet medical needs. We bring together a unique and varied set of talents to accomplish this goal. If you …See details»
www.precirix
May 11, 2024 Precirix has a robust end-to-end TRT supply chain Isotope Supply Manufacturing Distribution •Reliable external partners •Ac-225 (E&Z, Ionetix, Von BV) •Ga-68 (E&Z) •I-131 – …See details»
Precirix - F6S
Precirix - PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single …See details»
Precirix 2025 Company Profile: Valuation, Funding
Precirix General Information Description. Developer of radio-immunotherapeutic drugs designed to offer a new generation of targeted cancer therapies. The company's drugs are based on the camelid immune system which uses …See details»
Precirix NV - Drug pipelines, Patents, Clinical trials - Synapse
Mar 8, 2025 Explore Precirix NV with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 2 news, Disease Domain:Neoplasms, Endocrinology and Metabolic Disease, …See details»
Meet our team - Precirix
Prior to joining Precirix, he was the CEO of Chord Therapeutics, a clinical stage biotech company active in neurology which was sold to Merck. Before that he served as CSO of Wilson …See details»
Precirix - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 7, 2025 Precirix - Developer of radiopharmaceuticals for treating cancer. Raised a total funding of $130M over 3 rounds from 11 investors. Founded by Tony Lahoutte in the year …See details»
www.precirix
Oct 31, 2024 Precirix’ CAM-TRT are designed as monotherapy with potential for combination synergies • Free choice of non-overlapping target epitopes enables combination with other Tx …See details»
Precirix - Overview, News & Similar companies | ZoomInfo.com
Oct 6, 2021 Precirix contact info: Phone number: +32 24799360 Website: www.precirix.com What does Precirix do? Precirix is a private, clinical-stage biopharmaceutical company …See details»
Precirix Company Profile Funding & Investors | YourStory
PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain …See details»
Precirix - Funding, Financials, Valuation & Investors - Crunchbase
Precirix is a platform that is developing radio-immunotherapeutic drugs for cancer patients. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Precirix - Forbion
Precirix is a private, clinical-stage biopharmaceutical company founded in 2014 as a spin-off from the University of Brussels. Precirix is dedicated to extending and improving the lives of cancer …See details»
Precirix enters into alliance with 3P Biopharmaceuticals for the ...
Aug 17, 2021 Precirix is a private, clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by designing and developing precision …See details»
Investors & Partners - Precirix
Fournier-Majoie foundation. The Fournier-Majoie Foundation for Innovation, founded in 2007 by Doctor Bernard Majoie helps, both operationally and financially, Researchers-Finders to …See details»
PRECIRIX® | Gimv
PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain …See details»
A Unique Targeted Radionuclide Therapy (TRT) Radiometal …
Precirix platform allows the design and development of novel radiopharmaceuticals or targeted radionuclide therapies, a technology in which radionuclides are attached to ligands that direct …See details»
Precirix - Products, Competitors, Financials, Employees, …
Precirix's lead program targets Fibroblast Activation Protein (FAP) as a potential alpha-emitting targeted radiotherapy, with ongoing research into multiple isotopes and combination therapies. …See details»